Molluscum vs. Genital Warts: How to Tell Them Apart

Molluscum contagiosum and genital warts are caused by entirely different viruses, look different under most circumstances, and follow different timelines in the body. Molluscum comes from a poxvirus; genital warts come from certain strains of human papillomavirus (HPV). Yet the two conditions share enough surface-level similarities that they regularly get confused, especially when bumps show up in the genital area. Understanding where these infections diverge and where they genuinely overlap helps you figure out what you are dealing with and what to do about it.

Two Different Viruses, Two Different Families

Molluscum contagiosum virus (MCV) belongs to the poxvirus family, putting it in the same broad group as smallpox and cowpox. It is a large, double-stranded DNA virus that replicates inside skin cells and produces the distinctive waxy bumps the infection is known for. HPV, the virus behind genital warts, belongs to a completely separate family called Papillomaviridae. Over 200 types of HPV have been identified, but genital warts are overwhelmingly caused by just two low-risk strains, HPV 6 and HPV 11. The “low-risk” label means these strains are not associated with cancer; the high-risk strains that can lead to cervical or other cancers (mainly HPV 16 and 18) rarely cause visible warts.

This viral distinction matters because it affects nearly everything downstream: how the bumps look, how long they last, how the immune system responds, and what treatments work. Lumping the two together because they both show up on genitals is a bit like confusing a cold with the flu because both make you cough.

What Each One Looks Like

In their classic forms, molluscum and genital warts are fairly easy to tell apart. Molluscum bumps are small, dome-shaped, and have a smooth, pearly or skin-colored surface. The hallmark feature is a tiny dimple or pit in the center of each bump, sometimes called an umbilication. If you squeeze a molluscum bump, a white, cheesy core comes out. Each bump is usually only a few millimeters across, though they can grow larger in people with weakened immune systems.

Genital warts, on the other hand, tend to have a rough, irregular surface. Small ones look like tiny raised dots; larger ones develop a cauliflower-like texture with finger-like projections. They can be flesh-colored, pink, or slightly darker than the surrounding skin. Unlike molluscum, they do not have a central dimple and do not produce a cheesy plug when pressed. Warts can appear singly, in clusters, or in large confluent masses, especially if left untreated.

The confusion arises because not every case fits the textbook description. Molluscum in the genital area can sometimes look verrucous, meaning warty and rough, mimicking genital warts closely enough to fool even experienced clinicians. A case report documented this overlap in immunocompetent individuals, noting that dermoscopy can help distinguish the two by looking for specific vascular patterns in the projections of each lesion.¹ If you are unsure which one you have, a clinician can often settle the question with a close visual exam or, in ambiguous cases, a skin biopsy.

Who Gets Each Infection

The populations affected by molluscum and genital warts overlap but are not identical. Molluscum contagiosum primarily affects children, sexually active young adults, and immunocompromised people of all ages.² In children, it typically spreads through skin-to-skin contact during play or through shared towels and pool surfaces, and the bumps tend to appear on the face, trunk, and limbs rather than the genitals. In adults, genital molluscum is almost always sexually transmitted.

Genital warts are overwhelmingly a sexually transmitted infection. They are most common in sexually active teens and young adults, with peak incidence in the late teens through late twenties. Unlike molluscum, genital warts in young children raise immediate concern about the possibility of sexual abuse, though non-sexual transmission is possible, particularly in children under four years old, through casual skin contact, vertical transmission during birth, or contact with contaminated surfaces.³ No laboratory test can definitively determine the route of HPV transmission in a child, which complicates these cases considerably.

How Each Infection Spreads

Both viruses spread through direct skin-to-skin contact, but their behavior on the body differs. Molluscum virus infects only the outermost layer of skin and does not penetrate deeper tissues or enter the bloodstream. A person with molluscum can spread it to other parts of their own body through scratching or shaving, a process called autoinoculation. This means a single genital bump can seed new bumps on the thighs, lower abdomen, or anywhere you touch afterward.

HPV also spreads through skin-to-skin contact, but it targets a slightly different cell type: the basal cells of the epithelium, which it reaches through tiny breaks or abrasions in the skin. Like molluscum, HPV stays local to the skin and mucous membranes rather than spreading through the bloodstream. However, HPV is more tenacious in another way: the virus can remain dormant in skin cells for months or even years before producing visible warts, making it difficult to pinpoint when or from whom you caught it. Molluscum has a shorter incubation period, typically two to seven weeks, though it can stretch to six months.

How the Immune System Handles Each Virus

Both molluscum and genital warts are self-limiting infections in most people with healthy immune systems, but the timelines differ. Molluscum typically resolves on its own within six to twelve months, though some cases drag on for two years or more. The virus does not integrate into host DNA and does not establish lifelong latency. Once your immune system clears it, the infection is gone, though you can catch it again from a new exposure.

HPV clearance follows a different pattern. Most HPV infections, including the strains that cause warts, are cleared by the immune system within one to two years. The clearance process depends heavily on a cell-mediated immune response. Research on regressing genital warts found that warts that were actively shrinking contained significantly more T lymphocytes and macrophages than non-regressing warts, with CD4-positive lymphocytes predominating both within the wart tissue and the surface epithelium.⁴ The pattern resembles a delayed-type hypersensitivity reaction, where the immune system mounts a targeted attack on infected cells.

When that immune response fails to engage properly, warts persist. Studies of patients with chronic, recurrent genital warts found that while they did have HPV-specific T cells both in their lesions and in their blood, the T cells infiltrating the warts recognized only a very narrow range of viral targets, while T cells in the blood recognized a broader set. This mismatch may explain why some people’s immune systems struggle to clear warts locally even though they can detect the virus in the blood.⁵ HPV has evolved several mechanisms to evade immune detection, including reducing the expression of toll-like receptors in persistent lesions, which normally serve as early-warning signals for the immune system.⁶

Molluscum contagiosum virus uses its own set of immune evasion tricks, including producing proteins that interfere with the host’s inflammatory signaling. But it generally cannot sustain this evasion as long as HPV can, which is why molluscum tends to resolve faster in immunocompetent people. The practical takeaway is that both conditions will usually clear without treatment, but “usually” and “quickly” are not the same thing, and the wait can last a year or more for either.

Treatment Approaches

Despite both being self-limiting, most people seek treatment, especially when bumps appear in the genital area. The treatment toolbox for each condition overlaps in some places and diverges in others.

Treating Genital Warts

Genital wart treatments fall into two broad categories: those the patient applies at home and those performed in a clinic. Patient-applied options include podofilox, which disrupts cell division and kills wart tissue; imiquimod cream, which works by stimulating the local immune response against HPV through toll-like receptor signaling; and sinecatechins ointment, a green-tea extract that appears to work by promoting cell death in infected tissue and modulating the inflammatory response to HPV.⁷

In-clinic treatments include cryotherapy (freezing with liquid nitrogen), trichloroacetic acid application, and electrosurgery. A systematic review found that cryotherapy’s clearance rates were comparable to trichloroacetic acid, podophyllin, and imiquimod, while electrosurgery showed a slight edge over cryotherapy for wart clearance. Cryotherapy did carry more immediate side effects like redness, stinging, and pain requiring painkillers, though it caused fewer erosions than some alternatives.⁸

One frustration with genital wart treatment is the recurrence rate. Even after successful clearance, warts come back in a significant fraction of cases because the treatments destroy visible wart tissue without necessarily eliminating all HPV-infected cells in the surrounding skin. Imiquimod’s immune-stimulating mechanism gives it a theoretical advantage here, since it encourages the body’s own defenses to target the virus, but recurrences still happen.

Treating Molluscum

Molluscum treatments lean more heavily on physical destruction. Cryotherapy and curettage (scraping the bumps off with a small blade) are the most common clinic-based approaches. These work well but can be uncomfortable, especially when there are many lesions. For genital molluscum in adults, clinicians sometimes use potassium hydroxide solution, which chemically dissolves the bumps over repeated applications.

Newer treatments have been in development. Clinical trials have tested a cantharidin-based drug-device combination and berdazimer gel, both showing promising results, though questions remain about whether they improve patient adherence to treatment schedules compared to existing options.⁹ Unlike genital warts, molluscum does not have an equivalent of imiquimod that specifically targets the virus through immune modulation, though imiquimod is sometimes used off-label for molluscum as well.

The biggest practical difference is that molluscum rarely recurs after clearance, while genital warts frequently do. Once your body has fought off molluscum, the infection is finished at that site. With genital warts, the virus can linger in surrounding skin and reactivate months later.

When Immune Systems Are Compromised

Both infections behave very differently in people with weakened immune systems, particularly those with advanced HIV. Molluscum in immunocompromised patients can produce enormous, disfiguring lesions that number in the hundreds and resist all standard treatments. Genital warts in the same population grow aggressively, cover large areas, and are extremely difficult to clear.

A pilot study of AIDS patients who had failed conventional treatments for both conditions found that topical cidofovir, an antiviral cream, cleared lesions in nearly all participants who completed therapy. Of 14 patients treated (10 with extensive HPV lesions and four with molluscum), 13 completed the course, and all 13 eventually cleared their infections.¹⁰ Cidofovir works against both viruses because it is a broad-spectrum antiviral that targets DNA replication, making it one of the few treatments effective against both conditions. However, it is not a first-line treatment for either condition in otherwise healthy people.

For people living with HIV, the introduction of effective antiretroviral therapy has dramatically reduced the severity of both infections by restoring immune function. When the immune system rebounds, molluscum and warts that previously resisted every treatment often begin to clear on their own.

Prevention and the Vaccine Question

One of the starkest differences between these two infections is that genital warts are vaccine-preventable, while molluscum is not. The quadrivalent HPV vaccine targets HPV types 6, 11, 16, and 18, covering the two strains responsible for about 90% of genital warts plus the two most dangerous cancer-causing strains. A systematic review of ten years of real-world data showed that in countries with high vaccine uptake, genital wart rates dropped by roughly 90% among vaccinated populations, with reductions of up to about 93% observed in young Australian women within four years of the vaccination program’s launch.¹¹ Herd immunity effects also reduced wart rates in unvaccinated young men and older women in high-uptake countries.

No vaccine exists for molluscum contagiosum, and none is currently in advanced development. Because molluscum is self-limiting and not linked to cancer, it has never attracted the same level of vaccine research funding as HPV. Prevention relies on avoiding direct skin contact with infected people, not sharing towels or razors, and using condoms, though condoms only protect the skin they cover and both viruses can infect surrounding areas.

The Emotional Burden

Both conditions carry a psychosocial weight that often surprises people who dismiss them as “just bumps.” Genital infections of any kind carry stigma, and the anxiety of an undiagnosed bump in the genital area can be substantial. A study evaluating quality of life and psychological distress in patients with various genital conditions found that anogenital warts and molluscum contagiosum both produced measurable impacts on quality of life, depression, anxiety, and stress scores, with genital warts scoring somewhat higher on these measures than molluscum.¹²

Part of the distress with genital warts stems from the HPV connection. Even though HPV 6 and 11 are not cancer-causing strains, many people hear “HPV” and immediately think of cervical cancer, leading to disproportionate fear. Molluscum, being caused by a poxvirus with no cancer association whatsoever, does not carry that particular burden, but it still produces anxiety about sexual transmission, partner disclosure, and the cosmetic impact of visible bumps. Both conditions benefit from frank conversations with a healthcare provider who can put the diagnosis in proper perspective.

Diagnostic Pitfalls and When to Get a Biopsy

Most genital molluscum and wart cases are diagnosed clinically, meaning a doctor looks at the bumps and makes a call based on their appearance. This works well when the presentation is classic, but there are several scenarios where a biopsy or further testing becomes important.

Atypical molluscum, where bumps lose their central dimple or develop a rough, warty surface, can convincingly mimic genital warts even in people with healthy immune systems.¹³ Giant molluscum lesions in immunocompromised patients can also look nothing like the textbook description. On the wart side, flat warts can sometimes be confused with molluscum, and early condylomata may appear as smooth papules before developing their characteristic rough surface.

The stakes of misdiagnosis are not trivial. If molluscum is mistaken for warts, you might undergo unnecessary HPV-specific treatments, or worse, be told you have an HPV infection and carry that psychological burden when you do not. If warts are mistaken for molluscum, you might miss the opportunity to discuss HPV vaccination with a partner or fail to get appropriate follow-up screening. When there is genuine uncertainty, a punch biopsy can settle the question definitively: under the microscope, molluscum produces distinctive viral inclusion bodies in the skin cells, while HPV-infected cells show a different pattern of changes. Dermoscopy, a non-invasive magnification tool, can also help distinguish the two by revealing the different vascular patterns each virus produces in the skin.

Can You Have Both at the Same Time?

Yes. Co-infection with both molluscum contagiosum virus and HPV is entirely possible, since the two viruses are unrelated and infection with one does nothing to protect against the other. This is most commonly seen in immunocompromised patients, where both infections may be present simultaneously in the genital area and where the large number of lesions makes clinical differentiation even harder. But it can happen in anyone. If you have bumps that look like a mix of both, with some showing the classic molluscum dimple and others looking rough and cauliflower-like, it is worth pointing this out to your clinician rather than assuming they are all one thing.

Co-infection does not change the fundamental approach to either condition. Each virus is treated independently: the molluscum bumps get molluscum-appropriate treatment, and the warts get wart-appropriate treatment. The immune response to one virus does not meaningfully help or hinder the immune response to the other, so clearing one infection does not accelerate or delay clearance of the other.